139 related articles for article (PubMed ID: 32165211)
21. The different HMGA1 expression of total population of glioblastoma cell line U251 and glioma stem cells isolated from U251.
Fan H; Guo H; Zhang IY; Liu B; Luan L; Xu S; Hou X; Liu W; Zhang R; Wang X; Pang Q
Brain Res; 2011 Apr; 1384():9-14. PubMed ID: 21300033
[TBL] [Abstract][Full Text] [Related]
22. Correlation between glioblastoma stem-like cells and tumor vascularization.
He H; Niu CS; Li MW
Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
[TBL] [Abstract][Full Text] [Related]
23. Effect of all-trans retinoic acid on the proliferation and differentiation of brain tumor stem cells.
Niu CS; Li MW; Ni YF; Chen JM; Mei JM; Li J; Fu XM
J Exp Clin Cancer Res; 2010 Aug; 29(1):113. PubMed ID: 20716331
[TBL] [Abstract][Full Text] [Related]
24. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
[TBL] [Abstract][Full Text] [Related]
25. Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity.
Zhang B; Sun J; Yu SP; Chen C; Liu B; Liu ZF; Ren BC; Ming HL; Yang XJ
Chin Med J (Engl); 2012 Dec; 125(24):4344-8. PubMed ID: 23253699
[TBL] [Abstract][Full Text] [Related]
26. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
27. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact.
Fornara O; Bartek J; Rahbar A; Odeberg J; Khan Z; Peredo I; Hamerlik P; Bartek J; Stragliotto G; Landázuri N; Söderberg-Nauclér C
Cell Death Differ; 2016 Feb; 23(2):261-9. PubMed ID: 26138445
[TBL] [Abstract][Full Text] [Related]
29. [Overexpressed miRNA-134b inhibits proliferation and invasion of CD133
Liu Y; Zhang B; Wen C; Wen G; Zhou G; Zhang J; He H; Wang N; Li W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):637-642. PubMed ID: 28502302
[TBL] [Abstract][Full Text] [Related]
30. FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells.
Torres Á; Arriagada V; Erices JI; Toro MLÁ; Rocha JD; Niechi I; Carrasco C; Oyarzún C; Quezada C
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208561
[TBL] [Abstract][Full Text] [Related]
31. Tropism of mesenchymal stem cell toward CD133
Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S
Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179
[TBL] [Abstract][Full Text] [Related]
32. Isolation and partial characterization of a new human glioblastoma cell line.
Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
34. Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones.
Iacopino F; Angelucci C; Piacentini R; Biamonte F; Mangiola A; Maira G; Grassi C; Sica G
PLoS One; 2014; 9(8):e105166. PubMed ID: 25121761
[TBL] [Abstract][Full Text] [Related]
35. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
[TBL] [Abstract][Full Text] [Related]
36. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T
PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
[TBL] [Abstract][Full Text] [Related]
39. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
[TBL] [Abstract][Full Text] [Related]
40. Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature.
Erhart F; Blauensteiner B; Zirkovits G; Printz D; Soukup K; Klingenbrunner S; Fischhuber K; Reitermaier R; Halfmann A; Lötsch D; Spiegl-Kreinecker S; Berger W; Visus C; Dohnal A
J Cell Mol Med; 2019 Jan; 23(1):281-292. PubMed ID: 30467961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]